ALNY:NASDAQ
Alnylam Pharmaceuticals, Inc.
219,89 USD
arrow_upward
+0,08%(+0,17) 1 D
219,89 USD
0,00% (0,00)
bedtimeEtter stengetid
Stengt: 5. okt., 16:00:02 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for ALNY …
Åpne
218,36 USD
Høy
222,08 USD
Lav
215,46 USD
Markedsverdi
29,42 mrd.
Snittvolum
1,55 mill.
Volum
1,00
P/E-forhold
37,42
52 u høy
495,55 USD
52 u lav
197,81 USD
EPS
5,88 USD
Beta
0,28
Utestående aksjer
133,81 mill.
Antall ansatte
2k
Åpne
218,36 USD
Høy
222,08 USD
Lav
215,46 USD
Markedsverdi
29,42 mrd.
Snittvolum
1,55 mill.
Volum
1,00
P/E-forhold
37,42
52 u høy
495,55 USD
52 u lav
197,81 USD
EPS
5,88 USD
Beta
0,28
Utestående aksjer
133,81 mill.
Antall ansatte
2k
Nyhetssaker
Fra nettkilder og nyhetspartnere
Benzinga
·
for 13 timer siden
Nasdaq 100 Records Have Rarely Been This Narrow, 55 Stocks Are Still Below 50-Day Average
Trefis
·
for 1 døgn siden
Alnylam Pharmaceuticals Stock: 5 Straight Red Days, Down 14%
Profil
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
Om Alnylam Pharmaceuticals, Inc.